A study for a 64 year old woman who takes Zyrtec, Myrbetriq, Restasis, Omega 3, Multivitamin, Celecoxib - from FDA reports


Summary

2,203 females aged 64 (±5) who take the same drugs are studied. This is a personalized study for a 64 year old female patient who has Seasonal Allergy, Incontinence, Oa, General Health, Dry Eye. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Apr, 27, 2017

2,203 females aged 64 (±5) who take Zyrtec, Myrbetriq, Restasis, Omega 3, Multivitamin, Celecoxib are studied.


Number of reports submitted per year:

Zyrtec, Myrbetriq, Restasis, Omega 3, Multivitamin, Celecoxib for a 64-year old woman.

Information of the patient in this study:

  • Age: 64
  • Gender: female
  • Conditions: Seasonal Allergy, Incontinence, Oa, General Health, Dry Eye
  • Drugs taken:
    • Zyrtec (cetirizine hydrochloride)
    • Myrbetriq (mirabegron)
    • Restasis (cyclosporine)
    • Omega 3 (cod liver oil)
    • Multivitamin (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e)
    • Celecoxib (celecoxib)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • rashes
  • headache
  • diarrhea
  • eye irritation
  • atrial fibrillation/flutter
  • weakness
  • paraesthesia
  • insomnia
  • drug ineffective
  • vision blurred
1 - 6 months:
  • drug ineffective
  • weakness
  • diarrhea
  • anaemia
  • diabetes
  • gastric ulcer
  • chest pain
  • indigestion
  • gastroenteritis
  • hyperglycemia
6 - 12 months:
  • vasculitis
  • diabetes
  • atrial fibrillation/flutter
  • renal failure acute
  • lacrimation increased
  • joint pain
  • bronchitis
  • pain in extremity
  • renal impairment
  • weakness
1 - 2 years:
  • drug hypersensitivity
  • sleep apnea syndrome
  • delirium
  • weight increased
  • skin irritation
  • foreign body sensation in eyes
  • fatigue
  • bladder disorder
  • speech impairment (adult)
  • erythema of eyelid
2 - 5 years:
  • joint pain
  • mobility decreased
  • chills
  • nausea and vomiting
  • pain
  • constipation
  • drug ineffective
  • spinal fracture
  • kidney small
  • blood potassium decreased
5 - 10 years:
  • muscle aches
  • agranulocytosis
  • fever
  • pleural effusion
  • constipation
  • drug ineffective
  • gastritis
  • dizziness
  • haematuria
  • lymph follicular hypertrophy
10+ years:
  • pneumonia
  • respiratory tract infection
  • nodule
  • road traffic accident
  • balance disorder
  • drug ineffective
  • joint pain
  • gait disturbance
  • dysstasia
  • back disorder
not specified:
  • nausea
  • fatigue
  • diarrhea
  • pain
  • fall
  • joint pain
  • dizziness
  • headache
  • high blood pressure
  • drug ineffective

Top conditions involved for these people *:

  • Rheumatoid Arthritis (322 people, 14.62%)
  • High Blood Cholesterol (226 people, 10.26%)
  • High Blood Pressure (225 people, 10.21%)
  • Pain (184 people, 8.35%)
  • Osteoporosis (174 people, 7.90%)

Top co-used drugs for these people *:

  • Synthroid (285 people, 12.94%)
  • Calcium (265 people, 12.03%)
  • Nexium (252 people, 11.44%)
  • Methotrexate (241 people, 10.94%)
  • Humira (240 people, 10.89%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Incontinence, Zyrtec, Dry eye, Restasis, Oa, Myrbetriq, Seasonal allergy, Omega 3, Multivitamin, General health, Celecoxib

You may be interested in these reviews

More reviews for: Incontinence, Zyrtec, Dry eye, Restasis, Oa, Myrbetriq, Seasonal allergy, Omega 3, Multivitamin, General health, Celecoxib